Abstract
Normal cell proliferation is closely regulated by proteins called cyclins. One of these, cyclin D1, in combination with its corresponding cyclin-dependent kinase (cdk), is essential for G1/S phase transition. Cyclin/cdk complexes are generally inhibited by cyclin-dependent kinase inhibitors(ckis), some of which are induced by wild-type p53. The aims of this study were: to investigate levels of cyclin D1 expression in transitional cell carcinoma (TCC) of the bladder; to correlate these results with data concerning the expression of p53, waf1, pRb and Ki67; and to determine whether cyclin D1 expression could predict clinical outcome. Paraffin-sections from 150 newly diagnosed bladder tumours (Ta/T1=97; T2–T4=53) were stained for cyclin D1 using immunohistochemistry and a cyclin D1 index assigned. These results were correlated with data relating to the expression of p53 and waf1 by the same tumours. A representative subset of 54 tumours (Ta/T1=28; T2–T4=26) was also stained for Ki67 and 55 were stained for pRb. The clinical course of each patient was recorded and multivariate analyses of risk factors for tumour recurrence, stage progression and overall survival were performed. Positive staining for cyclin D1 was found in 83% of tumours. The staining pattern varied between tumours with nuclear, cytoplasmic or a combination of the two evident in different tumours. 89% of Ta/T1 and 74% of T2–T4 tumours showed nuclear staining with or without cytoplasmic staining. The median value for cyclin D1 staining was significantly higher in Ta/T1 tumours (41%) compared with T2–T4 tumours (8%, P< 0.005) with 26% of muscle-invasive tumours demonstrating absent staining. In addition, the median value for cyclin D1 staining was significantly higher in G1/G2 tumours (43%) compared with G3 tumours (14%, P< 0.005). There was a significant positive correlation between expression of cyclin D1 and waf1 expression (P< 0.0001) as well as pRb expression but not between cyclin D1 expression and expression of p53. Ki67 expression was significantly associated with increasing tumour stage (P< 0.005) and histological grade (P< 0.05) but did not correlate with cyclin D1 expression. A cyclin D1 index ≥ 8% was associated with significantly better survival in those patients with muscle-invasive disease (T2–T4). In addition, there was a significantly higher progression rate for those patients with Ta/T1 disease whose tumours demonstrated cytoplasmic cyclin D1 staining. These results indicate that cyclin D1 expression is significantly higher in low-stage, well differentiated bladder tumours and strongly correlates with waf1 expression. In a multivariate analysis, cyclin D1 expression is an independent prognostic indicator of survival in those patients with muscle-invasive disease. © 2001 Cancer Research Campaign http://www.bjcancer.com
Similar content being viewed by others
Article PDF
Change history
16 November 2011
This paper was modified 12 months after initial publication to switch to Creative Commons licence terms, as noted at publication
References
Altman DG (1991) Practical Statistics for Medical Research. Chapman and Hall: London
Barbareschi M, Pelosio P, Caffo O, Buttitta F, Pellegrini S, Barbazza R, Dalla Palma P, Bevilacqua G and Marchetti A (1997) Cyclin-D1-Gene amplification and expression in breast carcinoma: relation with clinicopathologic characteristics and with retinoblastoma gene product, p53 and p21WAF1immunohistochemical expression. Int J Cancer 74: 171–174
Bringuier PP, Tamimi Y, Schuuring E and Schalken J (1996) Expression of cyclin D1 and EMS1 in bladder tumours; relationship with chromosome 11q13 amplification. Oncogene 12: 1747–1753
Chen X, Bargonetti J and Prives C (1995) P53, through p21 (WAF1/CIP1), induces cyclin D1 synthesis. Cancer Res 55: 4257–4263
Cote RJ, Dunn MD, Chatterjee SJ, Stein JP, Shi S, Tran Q, Hu SX, Xu HJ, Groshen S, Taylor CR, Skinner DG and Benedict WF (1998) Elevated and absent pRB expression is associated with bladder cancer progression and has cooperative effects with p53. Cancer Res 58: 1090–1094
DeCaprio JA, Ludlow JW, Lynch D, Furukawa Y, Griffin J, Piwnica-Worms H, Huang CM and Livingston DM (1989) The product of the retinoblastoma susceptibility gene has properties of a cell cycle regulatory element. Cell 58: 1085–1095
Dulic V, Drullinger LF, Lee E, Reed SI and Stein GH (1993) Altered regulation of G1 cyclins in senescent human fibroblasts: accumulation of inactive cyclin E-cdk2 and cyclin D1-cdk2 complexes. Proc Natl Acad Sci USA 90: 11034–11038
Dyson N (1998) The regulation of E2F by pRb-family proteins. Genes and Dev 12: 2245–2262
Gillett CE, Fantl V, Smith R, Fisher C, Bartek J, Dickson C, Barnes D and Peters G (1994) Amplification and over-expression of cyclin D1 in breast cancer detected by immunohistochemical staining. Cancer Res 54: 1812–1817
Grossman HB, Liebert M, Antelo M, Dinney CPN, Hu S, Palmer JL and Benedict WF (1998) P53 and RB expression predict progression in T1 bladder cancer. Clin Cancer Res 4: 829–834
Hiyama H, Iavarone A, Labaer J and Reeves SA (1997) Regulated ectopic expression of cyclin D1 induces transcriptional activation of the cdk inhibitor p21 gene without altering cell cycle progression. Oncogene 14: 2533–2542
Ishikawa T, Furihata M, Ohtsuki Y, Murakami H, Inoue A and Ogoshi S (1998) Cyclin D1 overexpression related to retinoblastoma protein expression as a prognostic marker in human oesophageal squamous cell carcinoma. Br J Cancer 77: 92–97
Keegan PE, Lunec J and Neal DE (1998) P53 and p53-regulated genes in bladder cancer. Br J Urol 82: 710–720
Lee CCR, Yamamoto S, Morimura K, Wanibuchi H, Nishisaka N, Ikemoto S, Nakatani T, Wada S, Kishimoto T and Fukkushima S (1997) Significance of cyclin D1 overexpression in transitional cell carcinomas of the urinary bladder and its correlation with histopathologic features. Cancer 79: 780–789
Liu Y, Martindale JL, Gorospe M and Holbrook NJ (1996) Regulation of p21 Wafl/CIP1 expression through mitogen-activated protein kinase signalling pathway. Cancer Res 56: 31–35
Lukas J, Pagano M, Staskova Z, Draetta G and Bartek J (1994) Cyclin D1 protein oscillates and is essential for cell cycle progression in human tumour cell lines. Oncogene 9: 707–718
Muller H, Lucas J, Schneider A, Warthoe P, Bartek J, Eilers M and Strauss M (1994) Cyclin D1 expression is regulated by the retinoblastoma protein. Proc Natl Acad Sci USA 91: 2945–2949
Osman I, Scher H, Zhang Z, Soos TJ, Hamza R, Eissa S, Khaled H, Koff A and Cordon-Cardo C (1997) Expression of cyclin D1, but not cyclins E and A, is related to progression in Bilharzial bladder cancer. Clin Cancer Res 3: 2247–2251
Pagano M, Theodoras AM, Tam SW and Draetta GF (1994) Cyclin D1-mediated inhibition of repair and replicative DNA synthesis in human fibroblasts. Genes Dev 8: 1627–1639
Rosenberg CL, Kim HG, Shows TB, Kronenberg HM and Arnold A (1991) Rearrangement and overexpression of D11S287E, a candidate oncogene on chromosome 11q13 in benign parathyroid tumours. Oncogene 6: 449–453
Schuuring E (1995) The involvement of the chromosome 11q13 region in human malignancies: cyclin D1 and EMS1 are two new candidate oncogenes – a review. Gene 159: 83–96
Schuuring E, Verhoeven E, Mooi WJ and Michalides RJ (1992) Identification and cloning of two overexpressed genes, U21B31 PRAD1 and EMS1, within the amplified chromosome 11q13 region in human carcinomas. Oncogene 7: 355–361
Sherr CJ (1994) G1 phase progression: cycling on cue. Cell 79: 551–555
Sherr CJ (1996) Cancer cell cycles. Science 274: 1672–1677
Sherr CJ and Roberts JM (1999) CDK inhibitors: positive and negative regulators of G1-phase progression. Genes Dev 13: 1501–1512
Shin KY, Kong G, Kim WS, Lee TY, Woo YN and Lee JD (1997) Overexpression of cyclin D1 correlates with early recurrence in superficial bladder cancers. Br J Cancer 75: 1788–1792
Stein JP, Ginsberg DA, Grossfield GD, Chatterjee SJ, Esrig D, Dickinson MG, Groshen S, Taylor CR, Jones PA, Skinner DG and Cote RJ (1998) Effect of p21Waf1/Clp1expression on tumour progression in bladder cancer. J Natl Cancer Institute 90: 1072–1079
Suwa K, Takano Y, Iki M, Takeda M, Asakura T, Noguchi S and Masuda M (1998) Cyclin D1 protein overexpression is related to tumour differentiation, but not to tumour progression or proliferative activity, in transitional cell carcinoma of the bladder. J Urol 160: 897–900
Weinberg RA (1995) The retinoblastoma protein and cell cycle control. Cell 81: 323–330
Zhang H, Hannon GJ and Beach D (1994) P21-containing cyclin kinases exist in both active and inactive states. Genes Dev 8: 1750–1758
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
From twelve months after its original publication, this work is licensed under the Creative Commons Attribution-NonCommercial-Share Alike 3.0 Unported License. To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/
About this article
Cite this article
Tut, V., Braithwaite, K., Angus, B. et al. Cyclin D1 expression in transitional cell carcinoma of the bladder: correlation with p53, waf1, pRb and Ki67. Br J Cancer 84, 270–275 (2001). https://doi.org/10.1054/bjoc.2000.1557
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1054/bjoc.2000.1557
Keywords
This article is cited by
-
Ki-67 and Cell Cycle Regulators p53, p63 and cyclinD1 as Prognostic Markers for Recurrence/ Progression of Bladder Urothelial Carcinoma
Pathology & Oncology Research (2018)
-
The impact of cyclin D1 overexpression on the prognosis of bladder cancer: a meta-analysis
World Journal of Surgical Oncology (2014)
-
CCND1/CyclinD1 status in metastasizing bladder cancer: a prognosticator and predictor of chemotherapeutic response
Modern Pathology (2014)
-
Advanced urothelial carcinoma: next-generation sequencing reveals diverse genomic alterations and targets of therapy
Modern Pathology (2014)
-
Clinicopathologic features of breast cancer patients with type 2 diabetes mellitus in southwest of China
Medical Oncology (2014)